Please login to the form below

antifungal

This page shows the latest antifungal news and features for those working in and with pharma, biotech and healthcare.

Insmed claims first FDA okay for limited population antibiotic

The Limited Population Pathway for Antibacterial and Antifungal Drugs (LPAD) was set up in 2016 to encourage and hasten the development of new antibiotics or antifungals for that address a limited

Latest news

GSK and Novartis lead at PM Society Digital Awards

Bayer, MSD and Teva all picked up a gold each, for work that included multichannel work in hypogonadism and budget modelling in antifungal prophylaxis.
Basilea bags $72m upfront from Pfizer for antifungal license

Swiss pharma company Basilea has signed up Pfizer as its commercial partner for new antifungal Cresemba in Europe, Russia, Turkey and Israel, hoping to accelerate sales of the drug. ... Basilea launched the antifungal in its first European markets last
Rare disease therapies head the ‘class of 2015’

isavuconazole. Cresemba. Invasive aspergillosis/mucomycosis. triazole antifungal. Basilea/Astellas. USA. ixazomib. Ninlaro. multiple myeloma.
FDA approves first female sexual disorder drug

The warning also extends to women who use other drugs that are moderate or strong inhibitors of the drug metabolising enzyme - a group which includes certain antibiotics and antifungals, HIV drugs
FDA panel backs Sprout Pharma's 'female Viagra'

commonly used antifungal.

More from news
Approximately 3 fully matching, plus 24 partially matching documents found.

Latest Intelligence

Deal Watch September 2016

Basilea has granted an exclusive licence for isavuconazole (an iv and oral antifungal for invasive aspergillosis and mucomycosis) to Asahi Kasei in Japan.
Astellas: Ten years young

class of OAB treatments to emerge in over 30 years, the antifungal Mycamine (micafungin) and the anti-infective Dificlir - the first new treatment in 50 years for clostridium difficile or c.
Medius Deal Watch table for March 2015

109. Astellas / Vical. Licence and collaboration. Preclinical antifungal ASP2397. 100.
Pharma deals during October 2013

This proved to be the case with Dow Pharmaceutical Sciences, which had undertaken development work for Anacor on the topical antifungal tavaborole for the treatment of onychomycosis under a 2004 master

More from intelligence
Approximately 0 fully matching, plus 4 partially matching documents found.

Latest appointments

AstraZeneca’s John Rex joins UK biotech F2G

new role Rex will be tasked with helping move F2G's first-in-class antifungal F901218 through phase II clinical trials. ... John Rex said: “I am delighted to have the opportunity to work more closely with F2G as we take the first orotomide antifungal
F2G appoints chief financial officer

Schmid brings over two decades of financial management experience to the antifungal drug discovery and development company, with particular expertise in mergers and acquisitions, licensing and public and private market transactions.
Cidara Therapeutics makes senior appointments

Balkovec has helped bring more than a dozen development candidates into clinical development, including the first approved echinocandin antifungal drug Cancidas (caspofungin), which he is additionally co-inventor of.

More from appointments
Approximately 0 fully matching, plus 3 partially matching documents found.

Featured jobs

Editorial Manager - MedComms: DOE

Senior Editorial Assistant – Greater Manchester: DOE

Associate Medical Director: Excellent PTO, bonus and 401k package

Digital Communications Lead, Healthcare Brand and Medical Commun...: up to £50K

Medical Writer: Bonus Scheme, PTO &Private Healthcare

Account Manager / Account Director: Competative

Healthcare Communications Account Directors x 2: Salary TBC

Account Manager: Negotiable

Associate Director: £75, 000-90, 000

Senior Account Manager: Competitive Salary Offered

Chief Medical Writer, Medical Communications, London, up to £90K...: up to £90K

Senior Developer with management potential, Healthcare Brand Com...: circa £50K

Engagement Specialist, Healthcare Brand Communications, London, ...: circa £50K

Experienced Medical Writers: Competitive Salary and Benefits

Account Manager- Healthcare Advertising: Negotiable

Account Director: Competitive Salary Offered

Medical (Scientific) Director: £120, 000 benefits

Account Director – Healthcare Marketing – Berks: Salary TBC

Business Development Director – Health Education: excellent commission

Principal Health Economist - North-West: Negotiable

Systematic Reviewer - Oxford: Negotiable

CALLING ALL SENIOR HEALTHCARE PR FREELANCERS!!!!! ACCOUNT DIRECT...: EXCELLENT DAY RATES AVAILABLE

Manager - Immunology, Therapeutic Area Communications & Publ...: Competitive Salary Offered

Business Director: Competitive Salary Offered

SAE – Healthcare PR – Award-Winning Consultancy: Salary TBC

Subscribe to our email news alerts

PMHub

Add my company

Random42 Scientific Communication

Random42 is the world's leading medical animation company. Over the past 25 years we have produced core digital assets for...

Latest intelligence

AstraZeneca’s oncology renaissance: Susan Galbraith played a key role in restoring AstraZeneca’s place in cancer drug development – she talks about the future of oncology and why there’s more to be done to...
Navigating the antibiotic resistance crisis: Blue Latitude Health speaks to Tara DeBoer, PhD, Postdoctoral Researcher and CEO of BioAmp Diagnostics to explore the antimicrobial resistance crisis, and learn how a simple tool could support physicians...
Combined immunotherapies – potential and pitfalls: ‘Combining therapeutic compounds is the first logical step towards better results, namely higher rates of patients responding to treatment, with deeper and more sustained responses’...